SCHEMBL16350197

SCHEMBL16350197

CC[C@@H]1[C@@H]2[C@H](CN1C(C)=O)C(C)(C)C2(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16316176 0.79 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL16350254 0.75 ATM (0.31)
SCHEMBL25334006 0.72 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL18882255 0.66 SMN1; SMN2 (0.36) SMN1; SMN2
SCHEMBL25334189 0.64
SCHEMBL14339364 0.63 OGA (0.33)
SCHEMBL16300572 0.62 ATM (0.32) SMN1; SMN2
SCHEMBL16349114 0.62 ATM (0.32) SMN1; SMN2
SCHEMBL16317190 0.62 ATM (0.32) SMN1; SMN2
SCHEMBL16316588 0.62 ATM (0.32) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449447-B2 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2008-11-11 US disclosed